LFB USA is not confined by science, but empowered by it, to cultivate truly life-changing therapeutics. LFB USA is rooted in science and driven to meet unmet medical need. LFB USA …

LFB USA is a company within the LFB Group, a leading European biopharmaceutical company specialized in innovative biotherapies, marketing its medicinal products around the world.

At LFB USA, we are powering the development and commercialization of highly innovative recombinant therapies to address an ever-growing set of unmet medical needs. To do this …

The proprietary rPRO Technology ™ that drives LFB S.A.'s product development enables production of innovative recombinant therapies that are more cost-effective and scalable …

LFB USA has a key role in developing LFB's pipeline in the US, focusing on research, clinical development and regulatory strategies and filings. For the Factor FVIIa (LR769) program, LFB …

LFB USA is led by a team of business experts and scientists with a successful track record of developing and commercializing important and highly innovative healthcare technologies and …

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, …

Within the LFB Group, which is a leader in the field of therapeutic proteins in France, LFB USA enables the production of life-saving medicines within the Group’s key areas of expertise and …

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, …

Contact Corporate headquarters for LFB USA: LFB USA, Inc. 175 Crossing Blvd. Framingham, MA 01702